This invention relates to the field of
medical device testing technology, specifically to the application of LC-MS / MS in determining the content of
indophenol sulfate and p-
cresol sulfate in a
hemoperfusion device. The method includes: mixing
plasma and
acetonitrile, vortexing and centrifuging, collecting the supernatant, eluting the supernatant through a C18
solid-phase extraction column, collecting the eluent, mixing the eluent with water and filtering to obtain the
test solution; performing liquid
chromatography and
mass spectrometry on the
test solution, wherein the mobile phase A of the liquid
chromatography is a 3-8 mmol / L gradient concentration
ammonium acetate solution containing 0.05%
ammonium formate by volume, and the mobile phase B is
methanol; S3: calculating the concentrations of
indophenol sulfate and p-
cresol sulfate in the
test solution based on the labeled curve. This invention, through dual purification pretreatment and multi-
ion-pair threshold matching technology, can effectively remove more than 95% of interfering
protein-binding toxoids. The interference
peak response value in blank
plasma is less than 5% of the target
analyte response value, solving the detection error problem caused by interference in traditional methods.